Abstract
Lung cancer is one of the most frequent neoplasms with the highest mortality rates worldwide. Despite the current treatments for this cancer, the survival rates after 5 years still remain very low, which indicates the need for alternatives to treat this disease. Cisplatin is the chemotherapic of primary choice for the treatment of lung cancer, however, its nephro and cardiotoxic effects l…